Visalytics
Visalytics
approved EB-2 (NIW)

Research Postdoctoral Fellow

Nanomedicine · Jordan · 2023-05-13

Processing Time
90 days
Decision Date
2023-05-13
Location
Maryland
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to improve the delivery of mRNA therapeutics to increase the effectiveness of gene therapies for incurable conditions. His work focuses on formulating and characterizing novel nanoparticles and developing advanced animal models to test therapeutics for brain diseases like Alzheimer's and anti-cancer drug delivery.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor addresses critical U.S. issues including high prescription drug costs, vaccine efficacy, and the sustainability of the biopharmaceutical industry.

2 Well-positioned to Advance the Endeavor Met

The petitioner's record of 9 publications, 2 patents, and 110 citations demonstrates a consistent record of success and influence in nanomedicine.

3 Waiver of Job Offer and Labor Certification Met

On balance, the petitioner's contributions to improving gene therapies and reducing chemotherapy side effects justify a waiver of the labor certification.

Why This Petition Was Approved

The petition was approved based on the petitioner's 9 peer-reviewed journal articles (6 first-authored), 2 published patents, and 110 citations. Additionally, he completed 26 peer reviews and secured 4 expert recommendation letters, satisfying all three Dhanasar prongs.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Patents
Reference Letters Independent
Grants
Judging Experience
Original Contributions

Similar Cases

Scientist

Biotechnology · China

WeGreened EB-2 (NIW) approved
Massachusetts 37 days 2025-07-07
The petitioner proposes to develop efficient, biocompatible lipid nanoparticles (LNPs) to serve as vehicles for delivering gene-based therapeutics and anticancer drugs. Her work focuses on optimizing mRNA-based vaccines, co-delivered chemotherapies, and non-invasive anesthetics to enhance targeting and minimize toxicity. She intends to continue leading LNP development for oral and ocular drug delivery systems within the pharmaceutical industry.
View Case

Assistant Professor

Pharmaceuticals · Syria

WeGreened EB-2 (NIW) approved
65 days 2022-03-23
The petitioner proposes to continue research in the development of new drug delivery carriers based on nanotechnology using a one-step reproducible process. This work focuses on developing DNA and RNA vaccines and treating diseases such as cancer, Alzheimer's, and diabetes. Additionally, the endeavor includes the development of new pediatric drugs designed to mask unpleasant tastes to ease ingestion for children.
View Case

Scientist

Pharmaceuticals · India

WeGreened EB-2 (NIW) approved
North Carolina 132 days 2024-05-17
The petitioner proposes to continue her research in pharmaceutical sciences, specifically focusing on advancing drug repurposing and the development of nanoparticle-based delivery systems. Her work aims to create smarter, more efficient ways to deliver medications for critical diseases such as cancer and COVID-19. This research is intended to provide faster, cost-effective pathways for translating laboratory discoveries into viable clinical treatments.
View Case

Research Scientist

Biotechnology · Iran

WeGreened EB-2 (NIW) approved
162 days 2025-04-17
The petitioner proposes to continue his research in molecular biomedicine, specifically focusing on the development of nanoparticle-based delivery systems. His work aims to improve targeted cancer therapies, including chemotherapy, immunotherapy, and tumor thermal therapy, to enhance therapeutic efficacy while reducing side effects. The intended impact is to advance cancer care and oncology breakthroughs within the U.S. healthcare system.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Nanotechnology cases More cases from Jordan

Case data sourced from publicly available petition decisions and case studies. Decision date: 2023-05-13.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 90 days
Criteria Met 3 / 3
Evidence Types 7

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,814
Success Rate 53.6%
Sustained 2,046
Dismissed 1,672

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in Jordan All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist